Approval · Notice of Compliance 22783 · 2019
ULTRAVATE: Notice of Compliance 22783
Issued October 15, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22783
- Date
- October 15, 2019
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
Medicinal ingredients
- HALOBETASOL PROPIONATE 0.05 PER